Anlon Healthcare Limited’s Initial Public Offer (IPO) was open for subscription on Aug 26, 2025 and will close on Aug 29, 2025. The company is expected to raise about ₹121 crore over a fresh issue by offering 1.33 crore equity shares.
Anlon Healthcare Limited IPO details at a glance:
• Public Offer Opens: Aug 26, 2025
• Public Offer Closes: Aug 29, 2025
• Size of the IPO: Approx. ₹121 crore
• Price Band: ₹86 – ₹91
• Lot Size: 164 equity shares
• Minimum Investment for Retail: Approx. ₹14,104
• Listing At: NSE & BSE
• Registrar: KFin Technologies Limited
Important Dates: Anlon Healthcare Limited IPO
• Bidding for Anchor Investors: Aug 25, 2025
• Finalisation of Basis of Allotment: Sep 01, 2025
• Start of Refunds: Sep 02, 2025
• Credit of Shares to Demat: Sep 02, 2025
• List on Stock Exchange: Sep 03, 2025
Anlon Healthcare Limited IPO has been 3.67 times subscribed. The segment-wise consolidated investors participation are as follows:
• Total Subscription: 3.67x
• Retail Investors: 25.05x
• Qualified Institutional Buyers (QIBs): 1.01x
• Non-Institutional Investors (NIIs): 2.72x
(Data: August 28, 2025 | 14:33)
Anlon Healthcare Limited: Company Overview
Anlon Healthcare Limited is a Rajkot, Gujarat based company dealing in research based pharma company. The company operates in pharmaceutical industry with a focus on manufacturing Active Pharmaceutical Ingredients (APIs) along with Pharmaceutical Intermediates, targeting local and global markets. The company’s operations are highly organized in pharmaceutical industry, with clients over 50 countries across the Americas, Europe, Africa, Middle East, and Asia.